Analysen von Richard Vosser
| 20.01.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 20.01.20 | Bayer Neutral | JP Morgan Chase & Co. | |
| 16.01.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 07.01.20 | Roche overweight | JP Morgan Chase & Co. | |
| 06.01.20 | Merck Neutral | JP Morgan Chase & Co. | |
| 06.01.20 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 06.01.20 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 06.01.20 | Merck Neutral | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 06.01.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 06.01.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 06.01.20 | Sanofi overweight | JP Morgan Chase & Co. | |
| 06.01.20 | Bayer Neutral | JP Morgan Chase & Co. | |
| 06.01.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 06.01.20 | Roche overweight | JP Morgan Chase & Co. | |
| 06.01.20 | GSK Neutral | JP Morgan Chase & Co. | |
| 02.01.20 | Roche overweight | JP Morgan Chase & Co. | |
| 16.12.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 10.12.19 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 06.12.19 | Merck Neutral | JP Morgan Chase & Co. | |
| 06.12.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 25.11.19 | Roche overweight | JP Morgan Chase & Co. | |
| 21.11.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 19.11.19 | Merck Neutral | JP Morgan Chase & Co. | |
| 18.11.19 | Bayer Neutral | JP Morgan Chase & Co. | |
| 18.11.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 14.11.19 | Merck Neutral | JP Morgan Chase & Co. | |
| 08.11.19 | Merck Neutral | JP Morgan Chase & Co. | |
| 05.11.19 | Merck Neutral | JP Morgan Chase & Co. | |
| 05.11.19 | Merck Neutral | JP Morgan Chase & Co. | |
| 04.11.19 | Merck Neutral | JP Morgan Chase & Co. | |
| 04.11.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 01.11.19 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 01.11.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 30.10.19 | Bayer Neutral | JP Morgan Chase & Co. | |
| 30.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 28.10.19 | Bayer Neutral | JP Morgan Chase & Co. | |
| 23.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 22.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 21.10.19 | Roche overweight | JP Morgan Chase & Co. | |
| 21.10.19 | Bayer Neutral | JP Morgan Chase & Co. | |
| 18.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 17.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 17.10.19 | Roche overweight | JP Morgan Chase & Co. | |
| 16.10.19 | Roche overweight | JP Morgan Chase & Co. | |
| 14.10.19 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 11.10.19 | Roche overweight | JP Morgan Chase & Co. | |
| 09.10.19 | Bayer Neutral | JP Morgan Chase & Co. | |
| 07.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 04.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 02.10.19 | Roche overweight | JP Morgan Chase & Co. | |